Abstract We have identified the most relevant properties of a commercial recombinant lactase from Bifidobacterium bifidum (RBBL, Saphera 2600 L) for milk hydrolysis, with a yeast neutral lactase (GODO ...

The large-scale production of recombinant proteins in plants is limited by relatively low yields and difficulties in extraction and purification. These problems were addressed by engineering ...

Finally, coculturing recombinant yeast with C. 001 under anaerobic conditions reduced p -cresol by 50%. These strategies have the potential to be applied for the efficient reduction of p -cresol.

Figure 1: Immunization with recombinant yeast elicits antigen-specific, T-cell protective, cytotoxic and proliferative responses. Figure 2: DCs internalize yeast and efficiently prime MHC class I ...

Recombinant human EPO regimens of 40–150 U/kg intravenously three times a week have been studied for prevention or treatment of uremic bleeding. [61, 62, 64] The goal of treatment with ...

The glycosaminoglycans (GAGs) heparan sulfate, dermatan sulfate, and heparin are important anticoagulants that inhibit clot formation through interactions with antithrombin and heparin cofactor II.

Antithrombin deficiency is associated with increased risk of venous thrombosis. In certain families, this condition is caused by pathogenic polymerization of mutated antithrombin in the blood. To ...